NCT04345913 2026-03-19Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting24 enrolled 24 charts
NCT04317105 2026-03-18Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTENNational Cancer Institute (NCI)Phase 1/2 Active not recruiting54 enrolled